EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis

Lijuan Dan, Yanwei Hao, Jiaxin Li, Tianyuan Wang, Weiwei Zhao, Hui Wang, Liyan Qiao, Peijun Xie

Frontiers in Pharmacology · 08.01.2024 · 14

DOI: 10.3389/fphar.2023.1287750 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.01.2024. Verfasst von Lijuan Dan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recently, multiple preclinical studies have reported the beneficial effect of berberine in the treatment of Alzheimer’s disease (AD). Nevertheless, the neuroprotective effects and possible mechanisms of berberine against AD are not universally recognized. This study aimed to conduct a systematic review and meta-analysis by integrating relevant animal studies to assess the neuroprotective effects and potential mechanisms of berberine on AD.

Methods

We systematically searched PubMed, Embase, Scopus and Web of Science databases that reported the effects of berberine on AD models up to 1 February 2023. The escape latency, times of crossing platform, time spent in the target quadrant and pro-oligomerized amyloid beta 42 (Aβ 1-42 ) were included as primary outcomes. The secondary outcomes were the Tau-ps 204, Tau-ps 404, β-site of APP cleaving enzyme (BACE1), amyloid precursor protein (APP), acetylcholine esterase (AChE), tumor necrosis factor ⍺ (TNF-α), interleukin 1β (IL-1β), IL-6, nitric oxide (NO), glial fibrillary acidic protein (GFAP), malonaldehyde (MDA), glutathione S-transferase (GST), glutathione (GSH), glutathione peroxidase (GPx), Beclin-1 and neuronal apoptosis cells. This meta-analysis was conducted using RevMan 5.4 and STATA 15.1. The SYRCLE’s risk of bias tool was used to assess the methodological quality.

Results

Twenty-two studies and 453 animals were included in the analysis. The overall results showed that berberine significantly shortened the escape latency ( p < 0.00001), increased times of crossing platform ( p < 0.00001) and time spent in the target quadrant ( p < 0.00001), decreased Aβ 1-42 deposition ( p < 0.00001), Tau-ps 202 ( p < 0.00001) and Tau-ps 404 ( p = 0.002), and improved BACE1, APP, AChE, Beclin-1, neuronal apoptosis cells, oxidative stress and inflammation levels.

Conclusion

Berberine may be a promising drug for the treatment of AD based on preclinical evidence (especially when the dose was 5–260 mg/kg). The potential mechanisms for these protective effects may be closely related to anti-neuroinflammation, anti-oxidative stress, modulation of autophagy, inhibition of neuronal apoptosis and protection of cholinergic system. However, these results may be limited by the quality of existing research. Larger and methodologically more rigorous preclinical research are needed to provide more convincing evidence.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseBerberineanimal modelmeta-analysissystematic review

Autor:innen und Institutionen

  • School of Clinical Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Geriatrics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Traditional Chinese medicine department, 363 Hospital of Chengdu, Chengdu, China.
  • Department of Geriatrics, Xi'an Hospital of Traditional Chinese Medicine, Xi'an, China.

Zitieren

APA

Dan, L., Hao, Y., Li, J., Wang, T., Zhao, W., Wang, H., Qiao, L., & Xie, P. (2024). Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1287750

Vancouver

Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H, et al. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis. Frontiers in Pharmacology. 2024;14. doi:10.3389/fphar.2023.1287750

BibTeX
@article{Dan2024,
  author = {Dan, Lijuan and Hao, Yanwei and Li, Jiaxin and Wang, Tianyuan and Zhao, Weiwei and Wang, Hui and Qiao, Liyan and Xie, Peijun},
  title = {Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fphar.2023.1287750}
}
Kostenlos starten →